NDC 70771-1626

FULVESTRANT

Fulvestrant

FULVESTRANT is a Intramuscular Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Cadila Healthcare Limited. The primary component is Fulvestrant.

Product ID70771-1626_0e88b518-f3b3-4a43-b795-f6d9dbc3b0c6
NDC70771-1626
Product TypeHuman Prescription Drug
Proprietary NameFULVESTRANT
Generic NameFulvestrant
Dosage FormInjection, Solution
Route of AdministrationINTRAMUSCULAR
Marketing Start Date2021-12-14
Marketing CategoryANDA /
Application NumberANDA215234
Labeler NameCadila Healthcare Limited
Substance NameFULVESTRANT
Active Ingredient Strength50 mg/mL
Pharm ClassesEstrogen Receptor Antagonist [EPC],Estrogen Receptor Antagonists [MoA],Selective Estrogen Receptor Modulators [MoA]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 70771-1626-8

2 SYRINGE, GLASS in 1 CARTON (70771-1626-8) > 5 mL in 1 SYRINGE, GLASS (70771-1626-2)
Marketing Start Date2021-12-14
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "FULVESTRANT" or generic name "Fulvestrant"

NDCBrand NameGeneric Name
0143-9022FulvestrantFulvestrant
0310-7720FulvestrantFulvestrant
0591-5019FulvestrantFulvestrant
0781-3079FulvestrantFulvestrant
0781-3492FulvestrantFulvestrant
16714-070FULVESTRANTfulvestrant
16714-118FulvestrantFulvestrant
16729-436FULVESTRANTFulvestrant
25021-462fulvestrantfulvestrant
43598-262FulvestrantFulvestrant
70121-1463FulvestrantFulvestrant
63323-715FulvestrantFulvestrant
67457-311FulvestrantFulvestrant
68462-317FulvestrantFulvestrant
70534-002fulvestrantfulvestrant
68001-424fulvestrantfulvestrant
68842-301FulvestrantFulvestrant
70860-211FulvestrantFulvestrant
71288-555FulvestrantFulvestrant
71731-6121FulvestrantFulvestrant
72603-105FulvestrantFulvestrant
0310-0720FASLODEXFulvestrant
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.